- Conditions
- Beta-Thalassemia
- Interventions
- ACE-536
- Drug
- Lead sponsor
- Celgene
- Industry
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 99 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2035
- U.S. locations
- 2
- States / cities
- Los Angeles, California • New York, New York
Source: ClinicalTrials.gov public record
Updated Jan 5, 2026 · Synced May 22, 2026, 5:57 AM EDT